Oxford BioMedica (OTCMKTS:OXBDF) Stock Price Down 4.9% - Time to Sell?

Key Points

• Oxford BioMedica's stock price decreased by 4.9% on Tuesday, trading at $8.00, marking a significant drop from its previous close of $8.41.
• Trading volume for the day was notably low at 1,350 shares, an 80% decline from the average volume of 6,834 shares.
• The company has a debt-to-equity ratio of 3.08 and a current ratio of 1.89, indicating financial challenges that investors should consider.

Oxford BioMedica (OTCMKTS:OXBDF - ) shares traded down 4.9% on Tuesday . The stock traded as low as $8.00 and last traded at $8.00. 1,350 shares changed hands during mid-day trading, a decline of 80% from the average session volume of 6,834 shares. The stock had previously closed at $8.41.

Oxford BioMedica Stock Performance

The company has a debt-to-equity ratio of 3.08, a current ratio of 1.89 and a quick ratio of 1.67. The company's 50 day moving average is $7.37 and its 200 day moving average is $5.36.

Oxford BioMedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.